Yolanda Falcon Garcia

Venture Capital | Science & Tech Investments | M&A | Board Member

📍 Greater Vigo Metropolitan Area, Spain🔄 Updated September 2026💼 17 investments📅 18 years investing🗓 Last invested Dec 2021
Angel investor🌍 Spain
17
Total investments
4
Early stage
5
Mid stage
4
Late stage
18y
Years active

Portfolio

13 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Dec 2021
LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins.
Board Observer
Sep 2021
Celtarys Research develops and commercializes new chemical tools to spread the use of fluorescence-based methods in drug discovery. Our chemical conjugation technology allows us to develop in a competitive manner and short time (<3 months) customized fluorescent ligands with optimal pharmacological and photophysical properties for any druggable target. We have initially applied our technology to develop versatile fluorescent GPCR ligands which we have externally validated in several HTS assays such as FRET, Fluorescence Polarization, High Content Screening or Flow Cytometry, avoiding the use of radioactivity. Products: We have a catalogue of 20 fluorescent ligands for different families of GPCRs, including adenosine, dopamine, serotonin, cannabinoid and muscarinic receptors. Compared to other available fluorescence-based technologies, our ligands are: -More flexible and efficient -With high affinity and selectivity for the target -With a wide variety of fluorochromes -Compatible with various assays: FRET, polarized fluorescence, High Content Screening, flow cytometry... -Rational design portfolio covering entire GPCR families - With low cost and scalable production Services: We also offer custom synthesis of specific fluorescent ligands for any target with therapeutic potential. Our technology allows us to develop in a competitive way and in a short time (<3 months) customized fluorescent ligands with optimal pharmacological and photophysical properties.
early stageBiotechnology
Board Observer
Jun 2020
Passionate about the revolution in the personal transportation business, we want to provide new mobility solutions through a right combination of advanced hardware and software technologies. With the transportation industry on the edge of disruption, our mission is to develop connected products and services designed to take driving experience to the next level. VMS was founded in 2016 as a Spin-out of the industrial-automotive group Marsan SL, based Spain. After years of research and prototype development, VMS is currently developing an innovative electric three-wheeled motorcycle with a patented damping and tilting system that provides a higher stability than any other three-wheeled vehicle. The result is a safer driving, comfort and improved user experience compared with conventional motorcycles. Cities around the world are evolving fast and urban mobility is no longer just a question of options but convenience, efficiency and ease of use. Electric vehicles and connectivity play a key role in this new reality, and emerging startups working across the spectrum of these technologies will be able to dominate the industry as long as they understand new consumer mobility needs.
Board Observer
Mar 2020
En Coinscrap Finance trabajamos para ser la Plataforma de Inteligencia Artificial de Salud Financiera del futuro utilizando datos transaccionales y economía del comportamiento. Ayudamos a bancos y aseguradoras a entender la situación financiera de sus clientes y a vender el producto que mejor se adapte, un win win tanto para las entidades financieras como para sus clientes minoristas.
Board Observer
Jan 2020
Codee is an automated code inspection platform that analyzes Fortran, C, and C++ code to ensure correctness, modernization, security and optimization. Codee enforces coding guidelines to enhance code quality, modernize legacy code, improve portability, secure code, and optimize performance—ultimately accelerating software delivery and helping teams meet industry standards. We are proud to serve leading corporate and institutional clients across diverse sectors, including high-performance computing and consumer electronics and, with a strong presence in the US, China, Israel, Australia, Saudi Arabia and Europe.
Board Member
Jul 2015
Centauri Biotech es una empresa especializada en aplicaciones de biomedicina para la sanidad veterinaria. Nuestras terapias utilizan los últimos descubrimientos en biotecnología y biomedicina para mejorar la salud de su animal. Estos tratamientos están indicados para patologías musculares, tendinitis, lesiones de ligamentos y articulaciones, así como fracturas complejas. Igualmente son efectivos en enfermedades en las que se encuentra alterado el sistema inmune del animal.
Board Member
Mar 2015
We spend more than 90% of our time in indoor environments, where classical location services based on GPS don’t work, and existing solutions are either very expensive or don´t provide enough accuracy. We provide cloud base outdoor and indoor positioning services with the higher precision and minimal infrastructure. Our indoor positioning technology is a unique technology that merges the pre-existing information in the environment (magnetic fields, Bluetooth, WIFI) with information from smartphones (gyroscope accelerometer and compass). The obtained position can have an average accuracy between 1-4 meters without the need of additional hardware to the smartphone. This real-time positioning technology allows the development of wayfinding and tracking solutions to improve users'​ experience in hospitals, shopping centers, or airports; facilitate transit and assistance for people with reduced mobility in different facilities with large attendance; optimize work services in security or maintenance services, or increase productivity by asset management in industries 4.0. Health, facility management, retail, transport, corporate buildings, events, industry 4.0, or education are some of the sectors where our technology has already been deployed by more than 3,000 developers, and it´s being used in more than 6,000 buildings from more than 70 countries In 2018, Situm has been listed in Gartner's "Magic Quadrant for Indoor Location Services"​ as one of the top 10 providers of indoor positioning services worldwide. Try it for free at situm.com
Board Member
2011
NANOGAP develops and manufactures novel nanomaterials for use in diverse markets and applications including: • Conductive: High performance silver nanowires and silver nanoparticles for printed electronics • Luminescent: Unique, customizable high Stokes shift nanomaterials for security printing • Antimicrobial: Silver Atomic Quantum Clusters are non-toxic and provide long-lasting performance at low concentrations in clear, colorless antimicrobial coatings • Catalytic: Atomic Quantum Clusters with strong catalytic activity due to quantum effects for a range of homogeneous and heterogeneous applications • Therapeutic: Atomic Quantum Clusters as topoisomerase inhibitors for cancer treatment Materials can be tailored to our customers’ exacting requirements including particle size, morphology, surface functionalization, and carrier fluid.
Board Member
2010
Experts in electrocardiography 360º gem-med develops advanced technology in the healthcare industry and is specialized in the field of electromedicine and cardiology. gem-med carry out research, innovate, develop and commercialize electromedical equipment. gem-med also provide eCardiology services and medical-technological solutions. gem-med knows healthcare organizations, from the most complex to the simplest, and works to join them in the challenge to keep up with the constant evolution and quest for efficiency and excellence that is demanded of them, providing ideal technology and services to help them achieve their aims.
Board Member
2008
Command Sergeant Major
late stageMilitary
Board Member
2008
At immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve performance in key areas of clinical research and diagnostic development. Our goal is to improve research and diagnostic performance by innovating and adapting new technology to collaborate building meaningful clinical investigation. We work to achieve customer satisfaction through quality and differentiation of our products. We are constantly learning and developing as a company and, in the same way, we expect our products and our way of working to be constantly improving for the benefit of all our collaborators.
late stageBiotechnology
Board Member
2008
From the green pastures of Galicia, with the best raw materials and a lot of R&D, we make cream cheeses and other innovative dairy products. An R&D&I department at the forefront of research and development, 3 production plants, and high flexibility allow us to adapt easily to the needs of our customers and markets. Using buttermilk, a differentiated raw material of high functional and nutritional value, we take quality and food safety as a hallmark. Cream cheeses, mascarpone, culinary yoghurt, and much more to enhance creativity and innovation in all types of dishes and preparations. With a presence in more than 40 countries on all 5 continents, we offer a complete range of products used by food industries, chefs, pastry-chefs and consumers all over the world. Quescrem, the cream-cheese [R]evolution.
Board Member
2008
Bit Oceans desarrolla soluciones software destinadas a evitar el fraude por la falsificación de documentos de cualquier tipo, para lo cual, además de su conocimiento experto, cuenta con tecnología patentada en España y Estados Unidos, y con Euro-PCT aprobada.
Experience · 20 entries
All (20)
Investments (17)
Board (17)
2021
Board Observer
Dec 2021
LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins.
Board Observer
Sep 2021
Celtarys Research develops and commercializes new chemical tools to spread the use of fluorescence-based methods in drug discovery. Our chemical conjugation technology allows us to develop in a competitive manner and short time (<3 months) customized fluorescent ligands with optimal pharmacological and photophysical properties for any druggable target. We have initially applied our technology to develop versatile fluorescent GPCR ligands which we have externally validated in several HTS assays such as FRET, Fluorescence Polarization, High Content Screening or Flow Cytometry, avoiding the use of radioactivity. Products: We have a catalogue of 20 fluorescent ligands for different families of GPCRs, including adenosine, dopamine, serotonin, cannabinoid and muscarinic receptors. Compared to other available fluorescence-based technologies, our ligands are: -More flexible and efficient -With high affinity and selectivity for the target -With a wide variety of fluorochromes -Compatible with various assays: FRET, polarized fluorescence, High Content Screening, flow cytometry... -Rational design portfolio covering entire GPCR families - With low cost and scalable production Services: We also offer custom synthesis of specific fluorescent ligands for any target with therapeutic potential. Our technology allows us to develop in a competitive way and in a short time (<3 months) customized fluorescent ligands with optimal pharmacological and photophysical properties.
early stageBiotechnology
2020
Board Observer
Jun 2020
Passionate about the revolution in the personal transportation business, we want to provide new mobility solutions through a right combination of advanced hardware and software technologies. With the transportation industry on the edge of disruption, our mission is to develop connected products and services designed to take driving experience to the next level. VMS was founded in 2016 as a Spin-out of the industrial-automotive group Marsan SL, based Spain. After years of research and prototype development, VMS is currently developing an innovative electric three-wheeled motorcycle with a patented damping and tilting system that provides a higher stability than any other three-wheeled vehicle. The result is a safer driving, comfort and improved user experience compared with conventional motorcycles. Cities around the world are evolving fast and urban mobility is no longer just a question of options but convenience, efficiency and ease of use. Electric vehicles and connectivity play a key role in this new reality, and emerging startups working across the spectrum of these technologies will be able to dominate the industry as long as they understand new consumer mobility needs.
Board Observer
Mar 2020
En Coinscrap Finance trabajamos para ser la Plataforma de Inteligencia Artificial de Salud Financiera del futuro utilizando datos transaccionales y economía del comportamiento. Ayudamos a bancos y aseguradoras a entender la situación financiera de sus clientes y a vender el producto que mejor se adapte, un win win tanto para las entidades financieras como para sus clientes minoristas.
Board Observer
Jan 2020
Codee is an automated code inspection platform that analyzes Fortran, C, and C++ code to ensure correctness, modernization, security and optimization. Codee enforces coding guidelines to enhance code quality, modernize legacy code, improve portability, secure code, and optimize performance—ultimately accelerating software delivery and helping teams meet industry standards. We are proud to serve leading corporate and institutional clients across diverse sectors, including high-performance computing and consumer electronics and, with a strong presence in the US, China, Israel, Australia, Saudi Arabia and Europe.
Show all 20 entries ↓
Investment activity
2008–2021 · 17 investments
200862010220112201522020320212
Recent (last 2 years)Earlier